Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Scientific Reports|April 18, 2023
Machine-learning predicts time-series prognosis factors in metastatic prostate cancer patients treated with androgen deprivation therapyShinpei Saito, Shinichi Sakamoto, Kosuke Higuchi, et al.
Japanese Journal of Clinical Oncology|July 20, 2025
Consecutive real-world treatment experience with a reduced starting dose of lenvatinib (14 mg) plus pembrolizumab for metastatic renal cell carcinomaTomokazu Sazuka, Kentaro Murakami, Hidetaka Nihei, et al.
The Prostate|September 10, 2023
Clinical utility of the prognostic nutritional index in patients with metastatic hormone-sensitive prostate cancer: A retrospective, multicenter, cohort studyYasutaka Yamada, Shinichi Sakamoto, Kodai Sato, et al.
Scientific Reports|June 27, 2024
Implications of unconventional histological subtypes on magnetic resonance imaging and oncological outcomes in patients who have undergone radical prostatectomyKoichiro Kurokawa, Yasutaka Yamada, Shinichi Sakamoto, et al.
Anticancer Research|November 29, 2023
Preoperative PI-RADS v2.1 Scoring System Improves Risk Classification in Patients Undergoing Radical ProstatectomyYudai Fukui, Yasutaka Yamada, Shinichi Sakamoto, et al.
Cancer Science|May 29, 2021
Functional analysis of LAT3 in prostate cancer: Its downstream target and relationship with androgen receptorJunryo Rii, Shinichi Sakamoto, Masahiro Sugiura, et al.
Scientific Reports|June 2, 2021
The heavy chain of 4F2 antigen promote prostate cancer progression via SKP-2Maihulan Maimaiti, Shinichi Sakamoto, Masahiro Sugiura, et al.
Scientific Reports|July 2, 2025
Initial report of prospective study of regional cooperation for imaging-based follow-up after curative renal cell carcinoma surgeryRyo Tsukamoto, Tomokazu Sazuka, Hiroaki Sato, et al.
Translational Oncology|October 23, 2020
Identification of AR-V7 downstream genes commonly targeted by AR/AR-V7 and specifically targeted by AR-V7 in castration resistant prostate cancerMasahiro Sugiura, Hiroaki Sato, Atsushi Okabe, et al.
Anticancer Research|January 30, 2026
Prolonged Castration Prior to Docetaxel Reduces Febrile Neutropenia in Patients With Metastatic Hormone-sensitive Prostate Cancer Receiving Triple TherapyYasutaka Yamada, Tomoki Shirafuji, Kodai Sato, et al.
Pageof 3